Reading the market regime before prices move
Reading the market regime before prices move
Every number here is computed from the traded ABT options chain. The call wall is where dealer hedging accumulates above spot and caps upside, the put wall is its mirror below, and the gamma flip is the level where hedging stops damping moves and starts amplifying them.
Computed
Earnings Oct 21, 2026 before the open · the market prices a ±1.94% move ($98.61 to $102.52) · its median actual move over the last 16 reports was ±3.98%.
Last completed session, from the Finviro engine close archive · today's session levels refresh every five minutes inside the platform.
Price moves between these levels whether you see them or not. The difference is knowing them before your decision, not after.
You can check SPY, QQQ, NVDA in full right now, with no subscription.
Abbott Laboratories is a company in the Healthcare sector, listed on the New York Stock Exchange since 1980, with a market value of about $167.35B. It is led by Robert Ford and has about 115,000 employees.
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products…
Its beta is 0.59: the stock is usually calmer than the broad market, so its moves are narrower than the index.
On the price was $100.57, below its 50-day simple average (DMA-50 at $105.67) by 4.8%, and below its 200-day average (DMA-200 at $102.59) by 2.0%. Price is below both averages: the medium- and long-term trend is down.
Revenue was $44.33B in fiscal year 2025, against $43.08B in 2021, a change of +2.9% over 4 years.
Out of every $100 of revenue, about $15 is left as net income after all costs and taxes, so the net margin is 15%.
The operating margin is 18%: what is left of revenue after operating costs, before interest and taxes.
Earnings per share were $3.73 in 2025, against $3.97 in 2021.
Free cash flow was $7.4B: the cash left after spending on operations and investment, which funds dividends and buybacks.
These numbers describe the company's size and profitability and change slowly, while gamma levels describe how the stock moves within the session.
